Hologic, Inc.

NasdaqGS:HOLX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 15.14 B

Share Price

USD 68.06

Avg Daily Volume

2,718,917

Change (1 day)

0.19%

Change (1 year)

-18.38%

Change (YTD)

-5.59%

Hologic, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 28, 2025: 18.33%

Hologic, Inc. EBIT Margin is 18.33% for the Trailing 12 Months (TTM) ending June 28, 2025, a -19.46% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Hologic, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 29, 2024 was 22.76%, a 24.86% change year over year.
Hologic, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 01, 2023 was 18.23%, a -51.13% change year over year.
Hologic, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 25, 2022 was 37.29%, a -20.33% change year over year.
Hologic, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 26, 2021 was 46.81%, a 181.74% change year over year.